www.rupeedesk.in
Stocks of major pharmaceutical companies are likely to move in line with the broader market, with stocks of companies announcing their quarterly earnings next week moving as per their results. There is no specific trigger for the pharma sector, so it is expected to move on the cue of the broader market. Pfizer Ltd, Wyeth Ltd, Sanofi India Ltd and Alembic Pharmaceuticals Ltd are the drug makers who will post their Jan-Mar earnings next week.
Also expect that any development on intellectual-property rights could move the stocks of US pharma companies' arms operating in India, including companies like Pfizer and Abbott India Ltd. According to reports, a decision on the issue is likely to come on Thursday, when the US Trade Representative will release its report that rates intellectual property regimes of different countries.
Stocks of major pharmaceutical companies are likely to move in line with the broader market, with stocks of companies announcing their quarterly earnings next week moving as per their results. There is no specific trigger for the pharma sector, so it is expected to move on the cue of the broader market. Pfizer Ltd, Wyeth Ltd, Sanofi India Ltd and Alembic Pharmaceuticals Ltd are the drug makers who will post their Jan-Mar earnings next week.
Also expect that any development on intellectual-property rights could move the stocks of US pharma companies' arms operating in India, including companies like Pfizer and Abbott India Ltd. According to reports, a decision on the issue is likely to come on Thursday, when the US Trade Representative will release its report that rates intellectual property regimes of different countries.
